Science Explorer Back to mapMap
Discussion
Researcher · Noxxon Pharma (Germany) · Germany

Dirk Zboralski

Dirk Zboralski publishes mostly in Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, on topics such as Peptidase Inhibition and Analysis, Chemokine receptors and signaling and Radiopharmaceutical Chemistry and Applications.

ORCID 0000-0002-2224-2452 OpenAlex
World rank
#821,619
of 7,710,434 ranked researchers
Rank in Germany
#40,408
of 364,343
Works
29
Citations
1.8k
Citations per work
61.0
h-index
14
i10-index 15Top 40% in Oncology
Dirk Zboralski

What does Dirk Zboralski research?

Dirk Zboralski's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (7%).

Health Sciences: 15 works · 52.8% of their workMedicine: 15 works · 52.8% of their workOncology: 8 works · 26.4% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 13.8% of their workGenetics: 2 works · 6.9% of their workHematology: 2 works · 5.7% of their workEverything else: 7 works · 24.2% of their workLife Sciences: 7 works · 23.0% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 16.1% of their workMolecular Biology: 5 works · 16.1% of their workImmunology and Microbiology: 2 works · 6.9% of their workImmunology: 2 works · 6.9% of their workTHEIR WORKDirk Zboralski29works
Life Sciences23%Health Sciences53%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1552.8%
  2. Everything else724.2%
    1. Biochemistry, Genetics and Molecular Biology516.1%
    2. Immunology and Microbiology26.9%
  1. 1Oncology26% of their works
  2. 2Molecular Biology16% of their works
  3. 3Radiology, Nuclear Medicine and Imaging14% of their works
  4. 4Immunology7% of their works
  5. 5Genetics7% of their works
  6. 6Hematology6% of their works

Research topics

Which keywords describe Dirk Zboralski's research?

The keywords of their largest research topics: Angiogenesis, PET Imaging, Tumor Microenvironment, Inflammation, Therapeutic Targets, Fibroblast Activation Protein, Immunosuppression and Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Angiogenesis203 topics
  2. PET Imaging162 topics
  3. Tumor Microenvironment142 topics
  4. Inflammation112 topics
  5. Therapeutic Targets112 topics
  6. Fibroblast Activation Protein91 topic
  7. Immunosuppression91 topic
  8. Cancer72 topics
  9. Cancer Metastasis71 topic
  10. Chemokine Receptors71 topic
  11. Radiopharmaceuticals71 topic
  12. Targeted Therapy71 topic
  13. Immune Checkpoint Blockade51 topic
  14. PD-1 and PD-L151 topic
  15. Cell Adhesion41 topic
  16. Chronic Lymphocytic Leukemia41 topic
  17. Dendritic Cells41 topic
  18. Genomic Aberrations41 topic
  19. Immunity41 topic
  20. Integrins41 topic
  21. Glycans31 topic
  22. Glycosylation31 topic

Where does Dirk Zboralski work?

Dirk Zboralski's main affiliation in the publication record is Noxxon Pharma (Germany), Germany.

How many publications and citations does Dirk Zboralski have?

OpenAlex counts 29 works and 1,769 citations for Dirk Zboralski, an h-index of 14, ranking #821,619 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Dirk Zboralski. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.